Antiretroviral Therapy and Efficacy After Virologic Failure on First-line Boosted Protease Inhibitor Regimens

Background. Virologic failure (VF) on a first-line ritonavir-boosted protease inhibitor (PI/r) regimen is associated with low rates of resistance, but optimal management after failure is unknown. Methods. The analysis included participants in randomized trials who experienced VF on a first-line regi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zheng, Yu, Hughes, Michael D., Lockman, Shahin, Benson, Constance A., Hosseinipour, Mina C., Campbell, Thomas B., Gulick, Roy M., Daar, Eric S., Sax, Paul E., Riddler, Sharon A., Haubrich, Richard, Salata, Robert A., Currier, Judith S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2014
Gaiak:
HIV/AIDS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4155445/
https://ncbi.nlm.nih.gov/pubmed/24842909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu367
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak